http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 29 Sep 2025 16:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+SUMMER+ROAD+LLC/25392631.html si-local-file:///var/storage/secattach/20250929/25392631.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+SUMMER+ROAD+LLC/25392631.html Mon, 29 Sep 2025 16:30:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+SUMMER+ROAD+LLC/25392631.html si-local-file:///var/storage/secattach/20250929/25392631.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+SUMMER+ROAD+LLC/25392631.html Mon, 29 Sep 2025 16:30:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+SUMMER+ROAD+LLC/25392631.html si-local-file:///var/storage/secattach/20250929/25392631.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+SUMMER+ROAD+LLC/25392631.html Mon, 29 Sep 2025 16:30:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25378489.html si-local-file:///var/storage/secattach/20250925/25378489.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25378489.html Thu, 25 Sep 2025 16:09:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25378489.html si-local-file:///var/storage/secattach/20250925/25378489.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25378489.html Thu, 25 Sep 2025 16:09:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25378489.html si-local-file:///var/storage/secattach/20250925/25378489.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Theratechnologies+Inc.+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25378489.html Thu, 25 Sep 2025 16:09:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Theratechnologies+Inc.++++For%3A+Sep+25/25377604.html si-local-file:///var/storage/secattach/20250925/25377604.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Theratechnologies+Inc.++++For%3A+Sep+25/25377604.html Thu, 25 Sep 2025 14:02:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Theratechnologies+Inc.++++For%3A+Sep+25/25377604.html si-local-file:///var/storage/secattach/20250925/25377604.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Theratechnologies+Inc.++++For%3A+Sep+25/25377604.html Thu, 25 Sep 2025 14:02:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Theratechnologies+Inc.++++For%3A+Sep+25/25377604.html si-local-file:///var/storage/secattach/20250925/25377604.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Theratechnologies+Inc.++++For%3A+Sep+25/25377604.html Thu, 25 Sep 2025 14:02:00 -0400 O.00673999 TH THTX http://www.streetinsider.com/Corporate+News/Future+Pak+completes+acquisition+of+Theratechnologies+for+%243.01+per+share/25377297.html <p>Theratechnologies Inc. (NASDAQ: THTX) announced the completion of its acquisition by CB Biotechnology, LLC, an affiliate of Future Pak, LLC. Under the arrangement, shareholders received $3.01 per share in cash plus one contingent value right per share for potential additional payments up to $1.19 if certain milestones are achieved.</p><p>The Montreal-based biopharmaceutical company said consideration for the shares has been remitted to Computershare Investor Services Inc. as depositary and will be paid to former shareholders. Each contingent value right entitles holders to aggregate payments up to $1.19 per right based on milestone achievements. An independent third-party valuator determined the fair market http://www.streetinsider.com/Corporate+News/Future+Pak+completes+acquisition+of+Theratechnologies+for+%243.01+per+share/25377297.html Thu, 25 Sep 2025 13:22:08 -0400 THTX http://www.streetinsider.com/Mergers+and+Acquisitions/Future+Pak+completes+acquisition+of+Theratechnologies+for+%243.01+per+share/25377297.html <p>Theratechnologies Inc. (NASDAQ: THTX) announced the completion of its acquisition by CB Biotechnology, LLC, an affiliate of Future Pak, LLC. Under the arrangement, shareholders received $3.01 per share in cash plus one contingent value right per share for potential additional payments up to $1.19 if certain milestones are achieved.</p><p>The Montreal-based biopharmaceutical company said consideration for the shares has been remitted to Computershare Investor Services Inc. as depositary and will be paid to former shareholders. Each contingent value right entitles holders to aggregate payments up to $1.19 per right based on milestone achievements. An independent third-party valuator determined the fair market http://www.streetinsider.com/Mergers+and+Acquisitions/Future+Pak+completes+acquisition+of+Theratechnologies+for+%243.01+per+share/25377297.html Thu, 25 Sep 2025 13:22:08 -0400 THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Press+Releases/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html <p align="justify">MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“<strong>Theratechnologies</strong>” or the “<strong>Company</strong>”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the <em>Business Corporations Act</em> (Québec) involving CB Biotechnology, LLC (the “<strong>Purchaser</strong>”), an affiliate of Future Pak, LLC (“<strong>Future Pak</strong>”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the &quot;<strong>Shares</strong>&quot;) for US$3.01 per Share in cash plus one contingent value right (“<strong>CVR</strong>”) per Share for additional aggregate cash payments of up to US$1.19 per CVR if certain http://www.streetinsider.com/Globe+Newswire/Theratechnologies+Announces+Completion+of+Acquisition+by+Future+Pak/25377294.html Thu, 25 Sep 2025 13:21:00 -0400 A.04664552 A.14191503 A.16129928 O.00673999 O.00791225 O.07556890 O.50482219 TH THTX